Time reduction was assessed in all patients with a stroke dispatch from the entire catchment area in STEMO weeks ( 3213 patients ) vs control weeks ( 2969 patients ) and in patients in whom STEMO was available and deployed ( 1804 patients ) vs control weeks ( 2969 patients ) .